San Francisco, CA, United States of America

Ursula Edman

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 1992.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ursula Edman

Introduction

Ursula Edman is a notable inventor based in San Francisco, CA. She has made significant contributions to the field of genetics, particularly in the study of Pneumocystis carinii. Her work has implications for the development of targeted therapies against infections caused by this organism.

Latest Patents

Ursula Edman holds a patent for the "Pneumocystis carinii dihydrofolate reductase gene and methods for its use." This patent involves the isolation and characterization of genetic material encoding dihydrofolate reductase (DHFR) of Pneumocystis carinii. The genetic material allows for the production of peptides that can be used in designing inhibitors specific for P. carinii DHFR, distinguishing it from DHFR in the host infected with P. carinii. Additionally, this genetic material can be utilized in hybridization assays.

Career Highlights

Ursula Edman is affiliated with the University of California, where she continues her research and innovation in genetics. Her work has been instrumental in advancing the understanding of Pneumocystis carinii and its associated challenges in medical science.

Collaborations

Ursula has collaborated with notable colleagues, including Daniel V Santi and Jeffrey C Edman. These collaborations have further enriched her research and contributed to the scientific community's understanding of genetic material related to Pneumocystis carinii.

Conclusion

Ursula Edman's contributions to genetic research, particularly her patent on Pneumocystis carinii dihydrofolate reductase, highlight her innovative spirit and dedication to advancing medical science. Her work continues to pave the way for new therapeutic approaches.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…